DNA molecules and future blockbuster therapeutics

Danquah, Michael K., Liu, S, Ho, J, & Forde, Gareth M. (2009) DNA molecules and future blockbuster therapeutics. In 8th World Congress of Chemical Engineering, Montreal, Canada.

View at publisher

Abstract

Deoxyribonucleic acid molecules are heralding a new generation of reverse - engineered biopharmaceuticals. In terms of potential application in gene medicine, plasmid DNA (pDNA) vectors have exceptional therapeutic and immunological profiles as they are free from safety concerns associated with viral vectors, display non-toxicity and are simpler to develop. This presentation will discuss the potential applications of pDNA molecules in vaccine development and gene therapy, pilot-scale production of pDNA-based biopharmaceuticals and the controlled delivery of therapeutic sequences in biodegradable polymers to different target cells via the nasal route.

Impact and interest:

Citation counts are sourced monthly from Scopus and Web of Science® citation databases.

These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.

Citations counts from the Google Scholar™ indexing service can be viewed at the linked Google Scholar™ search.

ID Code: 82840
Item Type: Conference Paper
Refereed: Yes
Divisions: Current > Schools > School of Chemistry, Physics & Mechanical Engineering
Current > QUT Faculties and Divisions > Science & Engineering Faculty
Copyright Owner: Copyright 2009 Authors
Deposited On: 26 Mar 2015 04:38
Last Modified: 31 Mar 2015 04:46

Export: EndNote | Dublin Core | BibTeX

Repository Staff Only: item control page